发明名称 |
Method of reducing total cholesterol level by administering matrilin-2 polypeptide |
摘要 |
The present invention provides, in part, methods and compositions for treating lipid disorders comprising administering a polypeptide that inhibits PCSK9. A novel method for identifying polypeptides that interact with PCSK9 is also provided. |
申请公布号 |
US9089522(B2) |
申请公布日期 |
2015.07.28 |
申请号 |
US200912993672 |
申请日期 |
2009.05.21 |
申请人 |
Merck Sharp & Dohme Corp. |
发明人 |
Zhang Qing;Murgolo Nicholas J.;Hedrick Joseph A. |
分类号 |
A61K38/17;A61K47/48;A61K31/366;A61K31/397;A61K38/39;A61K45/06;C07K14/78;G01N33/573 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
Thampoe Immac J.;Su Li |
主权项 |
1. A method for reducing total cholesterol level, low density lipoprotein cholesterol level, apolipoprotein B level, total cholesterol/high density lipoprotein ratio or low density lipoprotein/high density lipoprotein ratio, comprising administering to a patient with a disorder of cholesterol or lipid homeostasis, a therapeutically effective amount of a composition comprising matrilin-2 polypeptide comprising the amino acid sequence selected from the group consisting of SEQ ID NO: 1, amino acids 24-956 of SEQ ID NO: 2 and SEQ ID NO: 2. |
地址 |
Rahway NJ US |